🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The combination of pEBV DNA (half-life) and PET-CT following 1 course of ch...
Status
Completed
Location
Department of Clinical Oncology, Prince of Wales Hospital
Start Date
2011-07
Trial ID
NCT01365208
Treatments Being Tested
To evaluate the efficacy and safety of Serplulimab in Combination With Doce...
Status
Unknown
Location
Zhang Zizhen
Start Date
2023-03-01
Trial ID
NCT05769725
Treatments Being Tested
Outcomes for patients with severe aplastic anemia (SAA) who are refractory ...
Status
Recruiting
Location
CHU Amiens
Start Date
2022-01-06
Trial ID
NCT05126849
Treatments Being Tested
Human induced pluripotent stem cells (iPSCs), are reprogrammed from somatic...
Status
Unknown
Location
Children Hospital and Institute of Child Health
Start Date
2019-08-01
Trial ID
NCT04097275
Treatments Being Tested
Rationale: The diaphragm is the principal respiratory muscle, which separa...
Status
Completed
Location
UMCG Groningen
Start Date
2023-01-28
Trial ID
NCT04735731
Treatments Being Tested
This is a clinical study on the efficacy and safety of low-dose CD20 monocl...
Status
Unknown
Location
Beijing Friendship Hospital
Start Date
2021-06-01
Trial ID
NCT05258136
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of CC-486 ...
Status
Completed
Location
Winship Cancer Institute of Emory University
Start Date
2015-02-13
Trial ID
NCT02269943
Treatments Being Tested
Outcomes for adult patients with Severe Aplastic Anemia (SAA) aged more tha...
Status
Recruiting
Location
Saint Louis hospital
Start Date
2025-01-24
Trial ID
NCT06646497
Treatments Being Tested
The purpose of this study is to evaluate the safety of the designed LMP1-CA...
Status
Unknown
Location
SecondNanjingMU
Start Date
2016-11
Trial ID
NCT02980315
Treatments Being Tested
This is a randomized, open-label, prospective, multicenter phase III superi...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center,
Start Date
2026-08-11
Trial ID
NCT07678229